BioNTech, Pfizer sue CureVac over COVID vaccine patent claims
Business Insurance - Jul 26, 2022
COVID-19 vaccine maker BioNTech said Tuesday that it and partner Pfizer filed a complaint in U.S. District Court in Massachusetts, seeking a judgment that they did not infringe U.S. patents held by rival CureVac....
Recommended Articles
Posted: Aug 22, 2023
South Korean insurers’ combined net profits increased to around 8 trillion South Korean won ($5.95 b...
Posted: Aug 22, 2023
According to a new report from Aon PLC, South Africa’s insurance market is continuing to see reduced...
Posted: Aug 22, 2023
Independent insurance brokerage Latin RE is the first Brazilian broker to get a license to operate d...